With regard to brain disease, previous studies showed that aberrant Shh signaling contributes to cerebellar tumors in both mice and humans [34] and Nmyc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth [35]. This evidence concerns the gene SHH and brain disorder.